Ehlis Ann-Christine, Zielasek Jürgen, Herrmann Martin J, Ringel Thomas, Jacob Christian, Fallgatter Andreas J
Laboratory for Psychophysiology and Functional Imaging, Department of Psychiatry and Psychotherapy, University Hospital of Wuerzburg, Fuechsleinstrasse 15, 97080, Wuerzburg, Germany.
Eur Arch Psychiatry Clin Neurosci. 2005 Oct;255(5):299-307. doi: 10.1007/s00406-005-0562-1. Epub 2005 Jan 7.
Disturbance of prefrontal brain functions is assumed to be responsible for prominent psychopathological symptoms in psychotic disorders. Treatment with atypical, in contrast to typical antipsychotics is considered as a possible strategy for an improvement of prefrontal brain function. In the present study, response control as a specific prefrontal brain function was assessed by means of the Nogo-anteriorization (NGA) derived from the event-related potentials elicited during a Go-NoGo task in a consecutive sample of 39 patients suffering from acute psychotic disorders (brief psychotic disorders, 298.8, n = 34 and schizoaffective disorders, 295.70, n = 5; cycloid psychoses according to the Leonhard classification). A highly significant positive correlation between the amount of antipsychotic medication in terms of chlorpromazine equivalents per day and the NGA as a measure of prefrontal response control was only found in the subgroup of patients treated exclusively or predominantly with atypical antipsychotics but not for those treated with typical antipsychotics. These results are in line with the notion that atypical antipsychotics may exert a beneficial effect on prefrontal brain function.
前额叶脑功能障碍被认为是导致精神障碍中显著精神病理症状的原因。与典型抗精神病药物相比,使用非典型抗精神病药物治疗被视为改善前额叶脑功能的一种可能策略。在本研究中,对39例急性精神障碍患者(短暂性精神病性障碍,298.8,n = 34;精神分裂症伴情感症状,295.70,n = 5;根据莱昂哈德分类的循环性精神病)的连续样本,通过在Go-NoGo任务期间诱发的事件相关电位得出的Nogo前化(NGA)来评估作为特定前额叶脑功能的反应控制。仅在仅使用或主要使用非典型抗精神病药物治疗的患者亚组中发现,以每天氯丙嗪等效剂量衡量的抗精神病药物用量与作为前额叶反应控制指标的NGA之间存在高度显著的正相关,而使用典型抗精神病药物治疗的患者则未发现这种相关性。这些结果与非典型抗精神病药物可能对前额叶脑功能产生有益影响的观点一致。